SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-035479
Filing Date
2022-12-14
Accepted
2022-12-14 19:24:50
Documents
1
Period of Report
2022-12-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 33376
  Complete submission text file 0001493152-22-035479.txt   34854
Mailing Address 108 DOCKSIDE CIRCLE WESTON FL 33327
Business Address
Glover Stephen C. (Reporting) CIK: 0001304406 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41184 | Film No.: 221463407

Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Issuer) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations